RUS-3108

N/A

Report date: 2024/11/21 17:28:28
NME

Base Information

Drug NameRUS-3108
Drug Alias NameRUS-3108
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBasement membrane-specific heparan sulfate proteoglycan core protein inducers
TargetsBasement membrane-specific heparan sulfate proteoglycan core protein
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDr.Reddy's Laboratories Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDr.Reddy's Laboratories Ltd
Active IndicationsN/A
Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A
Related LinksDrugBank